THE IMMUNOINFLAMMATORY PROCESS IN TYPE 2 DIABETES MELLITUS. HOW CAN WE HELP?

Introduction: Type 2 diabetes mellitus (T2DM) is considered the epidemic of the 21st century, with more than 220 million sick people worldwide. It is calculated that this number will triplicate by 2030. It is present mainly in subjects over the age of 40, however, its association with obesity has in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of nutrition and metabolism 2017-10, Vol.71 (Suppl. 2), p.163
1. Verfasser: Valdes-Ramos, Roxana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Suppl. 2
container_start_page 163
container_title Annals of nutrition and metabolism
container_volume 71
creator Valdes-Ramos, Roxana
description Introduction: Type 2 diabetes mellitus (T2DM) is considered the epidemic of the 21st century, with more than 220 million sick people worldwide. It is calculated that this number will triplicate by 2030. It is present mainly in subjects over the age of 40, however, its association with obesity has increased its prevalence in younger subjects. The nutritional transition in which many countries are immersed, with a rapid change in family income, the adoption of inadequate lifestyles and very low levels of physical activity, have led to an increase in prevalence of diabetes. Its aetiology involves the immune system in a very important way. Obectives: To review the conditions in the immunoinflammatory process that lead to the development of T2DM and its complications, in search of ways to improve the condition. Development: T2DM is a pathology resulting from two main conditions in glucose metabolism, a decrease in the production of insulin or an increased resistance to it. Diabetes is closely related to an alteration of the innate immune system, with the production of pro-inflammatory cytokines and adipokines in a chronic way. Insulin resistance develops before the increase in some inflammatory markers such as C-reactive protein and plasminogen activator 1, among others. Tumor necrosis factor alfa, interleukins 1 alfa and beta, interleukin 6, interferon gamma, retinol binding protein and resistin are increased in type 2 diabetes mellitus. On the other hand, we can find decreases in adiponectin, leptin, ghrelin, visfatin and omentin production. The immunoinflammatory process is responsible for the complications such as retinopathy, nefropathy, neuropathy, cardiovascular and peripheral vascular diseases, as well as periodontal pathologies. There are several low-cost and widely available interventions that may be useful in decreasing or controlling the inflammatory process, such as supplementation with various vitamins, polyunsaturated fatty acids, etc. Conclusions: T2DM is a pathology, where cause and effect are related to the innate immune system, thus, by controlling this inflammatory process, we can avoid the consequent complications of the disease.
doi_str_mv 10.1159/000480486
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2061903325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2061903325</sourcerecordid><originalsourceid>FETCH-proquest_journals_20619033253</originalsourceid><addsrcrecordid>eNqNissKgkAUQIcoyB6L_uBCa-vO-F6F2Q0HZlRyIlxJC1tIZGX9fy36gODAWZzD2ILjinMvWiOiG37xB8ziruB25EfBkFkoPLT9EIMxm_R9i8hF6HoWUyYlkFofs1xmexVrHZv8UEFxyBMqS5AZmKogELCT8ZYMlaBJKWmO5QrS_ARJnMGJICVVbGZsdDlf-2b-85Qt92SS1L4_u8e76V91272ft2-qBfo8QscRnvPf9QFF_jo4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2061903325</pqid></control><display><type>article</type><title>THE IMMUNOINFLAMMATORY PROCESS IN TYPE 2 DIABETES MELLITUS. HOW CAN WE HELP?</title><source>Jstor Complete Legacy</source><source>Karger Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Valdes-Ramos, Roxana</creator><creatorcontrib>Valdes-Ramos, Roxana</creatorcontrib><description>Introduction: Type 2 diabetes mellitus (T2DM) is considered the epidemic of the 21st century, with more than 220 million sick people worldwide. It is calculated that this number will triplicate by 2030. It is present mainly in subjects over the age of 40, however, its association with obesity has increased its prevalence in younger subjects. The nutritional transition in which many countries are immersed, with a rapid change in family income, the adoption of inadequate lifestyles and very low levels of physical activity, have led to an increase in prevalence of diabetes. Its aetiology involves the immune system in a very important way. Obectives: To review the conditions in the immunoinflammatory process that lead to the development of T2DM and its complications, in search of ways to improve the condition. Development: T2DM is a pathology resulting from two main conditions in glucose metabolism, a decrease in the production of insulin or an increased resistance to it. Diabetes is closely related to an alteration of the innate immune system, with the production of pro-inflammatory cytokines and adipokines in a chronic way. Insulin resistance develops before the increase in some inflammatory markers such as C-reactive protein and plasminogen activator 1, among others. Tumor necrosis factor alfa, interleukins 1 alfa and beta, interleukin 6, interferon gamma, retinol binding protein and resistin are increased in type 2 diabetes mellitus. On the other hand, we can find decreases in adiponectin, leptin, ghrelin, visfatin and omentin production. The immunoinflammatory process is responsible for the complications such as retinopathy, nefropathy, neuropathy, cardiovascular and peripheral vascular diseases, as well as periodontal pathologies. There are several low-cost and widely available interventions that may be useful in decreasing or controlling the inflammatory process, such as supplementation with various vitamins, polyunsaturated fatty acids, etc. Conclusions: T2DM is a pathology, where cause and effect are related to the innate immune system, thus, by controlling this inflammatory process, we can avoid the consequent complications of the disease.</description><identifier>ISSN: 0250-6807</identifier><identifier>EISSN: 1421-9697</identifier><identifier>DOI: 10.1159/000480486</identifier><language>eng</language><publisher>Basel: S. Karger AG</publisher><subject>Adiponectin ; C-reactive protein ; Cytokines ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetic neuropathy ; Dietary supplements ; Epidemics ; Fatty acids ; Ghrelin ; Glucose metabolism ; Health ; Immune system ; Inflammation ; Innate immunity ; Insulin ; Insulin resistance ; Interferon ; Interleukin 6 ; Interleukins ; Leptin ; Metabolism ; Nutrition ; Pathology ; Periodontics ; Physical activity ; Polyunsaturated fatty acids ; Proteins ; Retinopathy ; Vascular diseases ; Vitamin A ; Vitamins</subject><ispartof>Annals of nutrition and metabolism, 2017-10, Vol.71 (Suppl. 2), p.163</ispartof><rights>Copyright S. Karger AG Oct 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Valdes-Ramos, Roxana</creatorcontrib><title>THE IMMUNOINFLAMMATORY PROCESS IN TYPE 2 DIABETES MELLITUS. HOW CAN WE HELP?</title><title>Annals of nutrition and metabolism</title><description>Introduction: Type 2 diabetes mellitus (T2DM) is considered the epidemic of the 21st century, with more than 220 million sick people worldwide. It is calculated that this number will triplicate by 2030. It is present mainly in subjects over the age of 40, however, its association with obesity has increased its prevalence in younger subjects. The nutritional transition in which many countries are immersed, with a rapid change in family income, the adoption of inadequate lifestyles and very low levels of physical activity, have led to an increase in prevalence of diabetes. Its aetiology involves the immune system in a very important way. Obectives: To review the conditions in the immunoinflammatory process that lead to the development of T2DM and its complications, in search of ways to improve the condition. Development: T2DM is a pathology resulting from two main conditions in glucose metabolism, a decrease in the production of insulin or an increased resistance to it. Diabetes is closely related to an alteration of the innate immune system, with the production of pro-inflammatory cytokines and adipokines in a chronic way. Insulin resistance develops before the increase in some inflammatory markers such as C-reactive protein and plasminogen activator 1, among others. Tumor necrosis factor alfa, interleukins 1 alfa and beta, interleukin 6, interferon gamma, retinol binding protein and resistin are increased in type 2 diabetes mellitus. On the other hand, we can find decreases in adiponectin, leptin, ghrelin, visfatin and omentin production. The immunoinflammatory process is responsible for the complications such as retinopathy, nefropathy, neuropathy, cardiovascular and peripheral vascular diseases, as well as periodontal pathologies. There are several low-cost and widely available interventions that may be useful in decreasing or controlling the inflammatory process, such as supplementation with various vitamins, polyunsaturated fatty acids, etc. Conclusions: T2DM is a pathology, where cause and effect are related to the innate immune system, thus, by controlling this inflammatory process, we can avoid the consequent complications of the disease.</description><subject>Adiponectin</subject><subject>C-reactive protein</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetic neuropathy</subject><subject>Dietary supplements</subject><subject>Epidemics</subject><subject>Fatty acids</subject><subject>Ghrelin</subject><subject>Glucose metabolism</subject><subject>Health</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Innate immunity</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Interferon</subject><subject>Interleukin 6</subject><subject>Interleukins</subject><subject>Leptin</subject><subject>Metabolism</subject><subject>Nutrition</subject><subject>Pathology</subject><subject>Periodontics</subject><subject>Physical activity</subject><subject>Polyunsaturated fatty acids</subject><subject>Proteins</subject><subject>Retinopathy</subject><subject>Vascular diseases</subject><subject>Vitamin A</subject><subject>Vitamins</subject><issn>0250-6807</issn><issn>1421-9697</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNissKgkAUQIcoyB6L_uBCa-vO-F6F2Q0HZlRyIlxJC1tIZGX9fy36gODAWZzD2ILjinMvWiOiG37xB8ziruB25EfBkFkoPLT9EIMxm_R9i8hF6HoWUyYlkFofs1xmexVrHZv8UEFxyBMqS5AZmKogELCT8ZYMlaBJKWmO5QrS_ARJnMGJICVVbGZsdDlf-2b-85Qt92SS1L4_u8e76V91272ft2-qBfo8QscRnvPf9QFF_jo4</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Valdes-Ramos, Roxana</creator><general>S. Karger AG</general><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20171001</creationdate><title>THE IMMUNOINFLAMMATORY PROCESS IN TYPE 2 DIABETES MELLITUS. HOW CAN WE HELP?</title><author>Valdes-Ramos, Roxana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_20619033253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adiponectin</topic><topic>C-reactive protein</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetic neuropathy</topic><topic>Dietary supplements</topic><topic>Epidemics</topic><topic>Fatty acids</topic><topic>Ghrelin</topic><topic>Glucose metabolism</topic><topic>Health</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Innate immunity</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Interferon</topic><topic>Interleukin 6</topic><topic>Interleukins</topic><topic>Leptin</topic><topic>Metabolism</topic><topic>Nutrition</topic><topic>Pathology</topic><topic>Periodontics</topic><topic>Physical activity</topic><topic>Polyunsaturated fatty acids</topic><topic>Proteins</topic><topic>Retinopathy</topic><topic>Vascular diseases</topic><topic>Vitamin A</topic><topic>Vitamins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valdes-Ramos, Roxana</creatorcontrib><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Annals of nutrition and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valdes-Ramos, Roxana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE IMMUNOINFLAMMATORY PROCESS IN TYPE 2 DIABETES MELLITUS. HOW CAN WE HELP?</atitle><jtitle>Annals of nutrition and metabolism</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>71</volume><issue>Suppl. 2</issue><spage>163</spage><pages>163-</pages><issn>0250-6807</issn><eissn>1421-9697</eissn><abstract>Introduction: Type 2 diabetes mellitus (T2DM) is considered the epidemic of the 21st century, with more than 220 million sick people worldwide. It is calculated that this number will triplicate by 2030. It is present mainly in subjects over the age of 40, however, its association with obesity has increased its prevalence in younger subjects. The nutritional transition in which many countries are immersed, with a rapid change in family income, the adoption of inadequate lifestyles and very low levels of physical activity, have led to an increase in prevalence of diabetes. Its aetiology involves the immune system in a very important way. Obectives: To review the conditions in the immunoinflammatory process that lead to the development of T2DM and its complications, in search of ways to improve the condition. Development: T2DM is a pathology resulting from two main conditions in glucose metabolism, a decrease in the production of insulin or an increased resistance to it. Diabetes is closely related to an alteration of the innate immune system, with the production of pro-inflammatory cytokines and adipokines in a chronic way. Insulin resistance develops before the increase in some inflammatory markers such as C-reactive protein and plasminogen activator 1, among others. Tumor necrosis factor alfa, interleukins 1 alfa and beta, interleukin 6, interferon gamma, retinol binding protein and resistin are increased in type 2 diabetes mellitus. On the other hand, we can find decreases in adiponectin, leptin, ghrelin, visfatin and omentin production. The immunoinflammatory process is responsible for the complications such as retinopathy, nefropathy, neuropathy, cardiovascular and peripheral vascular diseases, as well as periodontal pathologies. There are several low-cost and widely available interventions that may be useful in decreasing or controlling the inflammatory process, such as supplementation with various vitamins, polyunsaturated fatty acids, etc. Conclusions: T2DM is a pathology, where cause and effect are related to the innate immune system, thus, by controlling this inflammatory process, we can avoid the consequent complications of the disease.</abstract><cop>Basel</cop><pub>S. Karger AG</pub><doi>10.1159/000480486</doi></addata></record>
fulltext fulltext
identifier ISSN: 0250-6807
ispartof Annals of nutrition and metabolism, 2017-10, Vol.71 (Suppl. 2), p.163
issn 0250-6807
1421-9697
language eng
recordid cdi_proquest_journals_2061903325
source Jstor Complete Legacy; Karger Journals Complete; Alma/SFX Local Collection
subjects Adiponectin
C-reactive protein
Cytokines
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetic neuropathy
Dietary supplements
Epidemics
Fatty acids
Ghrelin
Glucose metabolism
Health
Immune system
Inflammation
Innate immunity
Insulin
Insulin resistance
Interferon
Interleukin 6
Interleukins
Leptin
Metabolism
Nutrition
Pathology
Periodontics
Physical activity
Polyunsaturated fatty acids
Proteins
Retinopathy
Vascular diseases
Vitamin A
Vitamins
title THE IMMUNOINFLAMMATORY PROCESS IN TYPE 2 DIABETES MELLITUS. HOW CAN WE HELP?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A12%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20IMMUNOINFLAMMATORY%20PROCESS%20IN%20TYPE%202%20DIABETES%20MELLITUS.%20HOW%20CAN%20WE%20HELP?&rft.jtitle=Annals%20of%20nutrition%20and%20metabolism&rft.au=Valdes-Ramos,%20Roxana&rft.date=2017-10-01&rft.volume=71&rft.issue=Suppl.%202&rft.spage=163&rft.pages=163-&rft.issn=0250-6807&rft.eissn=1421-9697&rft_id=info:doi/10.1159/000480486&rft_dat=%3Cproquest%3E2061903325%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2061903325&rft_id=info:pmid/&rfr_iscdi=true